Skip to content

DIFARMEX: what changed

BE 0453.209.833Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€4,091
2024 · €8,660-€12,751
Equity
€200,895
2024 · €204,986-€4,091
Cash
€87
2024 · €33+€54
Balance sheet total
€290,081
2024 · €299,190-€9,109

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€6,677

    down €6,677 (-2.3%), from €296,671 to €289,994

Equity and liabilities
  • Debts after one year -€90,000

    no longer reported in 2025; in 2024 it stood at €90,000

  • Other debts +€86,253

    up €86,253 (+3,010%), from €2,866 to €89,119

  • Profit (loss) carried forward -€4,091

    down €4,091 (-5.6%), from -€72,784 to -€76,876

Income statement
  • Gross operating margin -€12,715

    down €12,715 (-76.6%), from €16,595 to €3,879

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €8,660
Gross operating margin -€12,715
Other operating charges -€36
Result 2025 -€4,091
lowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€90,054
Investment €0
Financing -€90,000
Cash 2024 €33
Net result for the year -€4,091
Depreciation +€6,677
Receivables within one year +€851
Deferred charges and accrued income +€1,635
Trade debts -€1,272
Other debts +€86,253
Accrued charges and deferred income +€1
Debts after one year -€90,000
Cash 2025 €87
brings cash intakes cash out
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €299,190 €290,081 -€9,109 -3.0%
Fixed assets 21/28 €296,671 €289,994 -€6,677 -2.3%
Tangible fixed assets 22/27 €296,671 €289,994 -€6,677 -2.3%
Land and buildings 22 €296,671 €289,994 -€6,677 -2.3%
Current assets 29/58 €2,519 €87 -€2,433 -96.6%
Amounts receivable within one year 40/41 €851 - -€851
Other amounts receivable 41 €851 - -€851
Cash at bank and in hand 54/58 €33 €87 +€54 +162%
Deferred charges and accrued income 490/1 €1,635 - -€1,635
Total equity and liabilities 10/49 €299,190 €290,081 -€9,109 -3.0%
Equity 10/15 €204,986 €200,895 -€4,091 -2.0%
Contributions 10/11 €86,769 €86,769 = 0.0%
Capital 10 €86,769 €86,769 = 0.0%
Issued capital 100 €86,769 €86,769 = 0.0%
Revaluation surpluses 12 €186,540 €186,540 = 0.0%
Reserves 13 €4,462 €4,462 = 0.0%
Non-distributable reserves 130/1 €4,462 €4,462 = 0.0%
Legal reserve 130 €4,462 €4,462 = 0.0%
Profit (loss) carried forward 14 -€72,784 -€76,876 -€4,091 -5.6%
Amounts payable 17/49 €94,204 €89,186 -€5,018 -5.3%
Amounts payable after more than one year 17 €90,000 - -€90,000
Financial debts 170/4 €90,000 - -€90,000
Amounts payable within one year 42/48 €4,138 €89,119 +€84,981 +2,054%
Trade debts 44 €1,272 - -€1,272
Suppliers 440/4 €1,272 - -€1,272
Other amounts payable 47/48 €2,866 €89,119 +€86,253 +3,010%
Accrued charges and deferred income 492/3 €66 €67 +€1 +2.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,677 €6,677 = 0.0%
Other operating charges 640/8 €1,212 €1,248 +€36 +2.9%
Gross operating margin 9900 €16,595 €3,879 -€12,715 -76.6%
Operating profit (loss) 9901 €8,706 -€4,045 -€12,751
Financial charges 65/66B €46 €46 = 0.0%
Recurring financial charges 65 €46 €46 = 0.0%
Profit (loss) for the period before taxes 9903 €8,660 -€4,091 -€12,751
Profit (loss) for the period 9904 €8,660 -€4,091 -€12,751
Profit (loss) for the period to be appropriated 9905 €8,660 -€4,091 -€12,751

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€114,483 to €120,098

Midpoint €116,823 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €200,895
Capitalised earnings €28,071 to €39,300
Indication €114,483 to €120,098

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€200,895
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€200,895

Capitalised earnings

net result for the year (9904)
2025
-€4,091
2024
€8,660
2023
€7,220
2022
€5,975
excluding non-recurring income and charges
€2,709
2021
€5,989
Average result
€3,930
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€28,071 / €32,750 / €39,300

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.